Biosafety Committee (IBC)
- Norman Campus
The OU Institutional Biosafety Committee (IBC) has the charge of reviewing and approving the biological safety of all OU Norman campus-related research activities involving recombinant or synthetic nucleic acid molecules, gene transfer, microorganisms, viruses, and biological toxins.
If it is determined that the proposed work meets these guidelines, a letter confirming this will be forwarded to the Office of Research Administration.
Should the work proposed fall into any existing NIH Recombinant or Synthetic Nucleic Acid category other than "exempt from the guidelines" (see a summary of the guidelines for clarification), a special meeting of the Institutional Biosafety Committee will be held to discuss the proposed research.
- The PI must contact the Insitutional Biosafety Committee Chair, Dr. Bruce Roe (325-4912), to discuss the planned activities, prior to the final grant submission, so that it can be determined if any recombinant or synthetic nucleic acid molecules or any potential biological hazardous work is being proposed.
- After a preliminary determination that recombinant or synthetic nucleic acid molecule activities or potentially biological hazardous work are being planned, the PI should submit the following to Dr. Roe for IBC review to verify that the proposed work is in compliance with all Federal, State and Local Guidelines and falls within the category "exempt from the guidelines" or requires the work be done under a specific biosafety containment level:
OU requires that every employee complete annual safety training for the types of work performed. Current Laboratory Safety (required for all laboratory personnel) and General Biosafety training is required for all personnel identified on any submitted IBC protocol. Bloodborne Pathogen training is additionally required for working with human cell lines. These training courses are found at https://www.ouhsc.edu/ehso/training-norman/new_logon.asp. Your logon will be the exact same logon you use for your e-mail.
Helpful Links to Regulatory Guidelines:
Conflict of Interest Policy: